Status:
COMPLETED
NUTS for the Prevention of Cardiovascular Disease in Chinese Adults
Lead Sponsor:
The George Institute for Global Health, China
Collaborating Sponsors:
Ningxia Medical University
Conditions:
Cardiovascular Diseases
Dyslipidemias
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study evaluates the feasibility of walnuts supplementation among population of high CVD risks over a period of 6 months. 70 participants will be controls receiving non-edible gifts. 70 participan...
Detailed Description
Increased consumption of nuts improves the levels of lipid risk factors associated with cardiovascular disease and consistently relates to lower risk of cardiovascular disease (CVD) in prospective coh...
Eligibility Criteria
Inclusion
- A history of CVD, defined on the basis of a prior hospitalisation for a myocardial infarction or stroke, unstable angina, coronary artery bypass graft, percutaneous coronary intervention (with or without stenting), peripheral revascularization (angioplasty or surgery), symptomatic with documented hemodynamically-significant carotid or peripheral vascular disease, or amputation secondary to vascular disease, OR
- Male aged \>60 years, or female aged\>65 years, AND
- With at least two of the following risk factors:
- Type 2 diabetes requiring treatment with at least two oral anti-hyperglycaemic agents and/or insulin
- Systolic blood pressure \> 140 mmHg while on one or more antihypertensive agents
- Current daily smoking
- Dyslipidaemia defined as HDL-cholesterol\<1.0mmol/L or LDL-cholesterol\>6.0mmol/L
- Micro or macro albuminuria
Exclusion
- Allergic to nuts (history of food allergy with hypersensitivity to any of the components of nuts)
- Other serious medical condition that prevents nut consumption (e.g. digestive disease with fat intolerance)
- Any medical condition thought to limit survival to less than 1 year
- Difficulty with consuming nuts (e.g. dental health issues that prevent chewing walnuts)
- Unwilling to consume nuts
Key Trial Info
Start Date :
October 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 24 2021
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04037943
Start Date
October 14 2019
End Date
December 24 2021
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yi Zhao
Yinchuan, Ningxia, China, 750004